Besides, by further investigating SEMA6B in multiple different malignancies, we also confirmed that SEMA6B high-expression is characteristic not only in THCA but also in clear cell renal carcinoma (KIRC) and stomach adenocarcinoma (STAD) (Figure 11). This evidence concerns the gene SEMA6B and gastric adenocarcinoma.